Date: September 2024
Location: On-demand webinar
Overview:
The evolving landscape of Rare Disease research has been fueled by continuous innovation across multiple fronts and is rife with opportunities to continue improving access and treatment options for patients around the world.
Clinical development is pushing boundaries, allowing for more meaningful treatment options to be made available to more patients across the globe while also developing more personalised medicines. In this webinar series, we explore some of the key emerging areas of opportunity and their impact on the current and future shape of this development landscape.
Attendees will learn about the innovations and impacts of:
- New product areas in Rare Disease
- Novel types of drugs and therapies (including GeneTx, CellTx, etc.) for Rare Disease patients and the future of development and access to these
- Global approaches to improving access for underserved patient populations including in China, India and the Middle East
- Innovations in managing large populations in Rare Disease research in China
Each panel discussion will shed light on individual facets of innovation. Viewed together, they provide valuable insight into the ways Rare Disease research is evolving to generate better access, treatment options and outcomes for patients. We also explore the roles sponsors, patient advocates, researchers and regulators play in addressing emerging challenges as we continue driving meaningful science and broader access.